Fractional flow reserve as a surrogate for inducible myocardial ischaemia

Nature Reviews Cardiology

Volumn 10, Issue 8, 2013, Pages 439-452

  Van De Hoef, Tim P ^a   Meuwissen, Martijn ^b   Escaned, Javier ^c   Davies, Justin E ^d   Siebes, Maria ^e   Spaan, Jos A E ^e   Piek, Jan J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b AMPHIA HOSPITAL   (Netherlands)

^c HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^d NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^e UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; PAPAVERINE; RADIOISOTOPE; VASODILATOR AGENT;

BLOOD FLOW VELOCITY; CLINICAL PRACTICE; CONCEPTUAL FRAMEWORK; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY CONSTRICTION; CORONARY ARTERY DILATATION; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY PRESSURE; CORONARY BLOOD VESSEL; CORONARY FLOW RESERVE; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; FRACTIONAL FLOW RESERVE; HEART HEMODYNAMICS; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; LEFT CORONARY ARTERY; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; REVIEW; RIGHT CORONARY ARTERY; VASCULAR RESISTANCE; VASODILATATION;

EID: 84881110699     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2013.86     Document Type: Review

References (139)

1. Boden, W. E. et al. Optimal medical therapy with or without PCI for stable coronary disease. N. Engl. J. Med. 356, 1503-1516 (2007).
2. Pursnani, S. et al. Percutaneous coronary intervention versus optimal medical therapy in stable coronary artery disease: A systematic review and meta-analysis of randomized clinical trials. Circ. Cardiovasc. Interv. 5, 476-490 (2012).
3. Shaw, L. J. et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: Results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation 117, 1283-1291 (2008).
4. Blankenship, J. C. et al. Ad hoc percutaneous coronary intervention: A consensus statement from the society for cardiovascular angiography and interventions. Catheter. Cardiovasc. Interv. 81, 748-758 (2013).
5. Topol, E. J. & Nissen, S. E. Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ischemic heart disease. Circulation 92, 2333-2342 (1995).
6. Mintz, G. S. et al. Limitations of angiography in the assessment of plaque distribution in coronary artery disease: A systematic study of target lesion eccentricity in 1,446 lesions. Circulation 93, 924-931 (1996).
7. Tonino, P. A. et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N. Engl. J. Med. 360, 213-224 (2009).
8. Tonino, P. A. et al. Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation. J. Am. Coll. Cardiol. 55, 2816-2821 (2010).
9. Pijls, N. H. et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study. J. Am. Coll. Cardiol. 56, 177-184 (2010).
10. Wijns, W. et al. Guidelines on myocardial revascularization. Eur. Heart J. 31, 2501-2555 (2010).
11. Levine, G. N. et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J. Am. Coll. Cardiol. 58, e44-e122 (2011).
12. Fearon, W. F. et al. Economic evaluation of fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease. Circulation 122, 2545-2550 (2010).
13. Tiefenbacher, C. P. & Chilian, W. M. Heterogeneity of coronary vasomotion. Basic Res. Cardiol. 93, 446-454 (1998).
14. Mosher, P., Ross, J. Jr, McFate, P. A. & Shaw, R. F. Control of coronary blood flow by an autoregulatory mechanism. Circ. Res. 14, 250-259 (1964).
15. Di Mario, C., Krams, R., Gil, R. & Serruys, P. W. Slope of the instantaneous hyperemic diastolic coronary flow velocity-pressure relation: A new index for assessment of the physiological significance of coronary stenosis in humans. Circulation 90, 1215-1224 (1994).
16. Spaan, J. A. Coronary diastolic pressure-flow relation and zero flow pressure explained on the basis of intramyocardial compliance. Circ. Res. 56, 293-309 (1985).
17. Gould, K. L., Lipscomb, K. & Hamilton, G. W. Physiologic basis for assessing critical coronary stenosis. Instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve. Am. J. Cardiol. 33, 87-94 (1974).
18. Kaul, S. & Jayaweera, A. R. Myocardial capillaries and coronary flow reserve. J. Am. Coll. Cardiol. 52, 1399-1401 (2008).
19. Gould, K. L. & Lipscomb, K. Effects of coronary stenoses on coronary flow reserve and resistance. Am. J. Cardiol. 34, 48-55 (1974).
20. Gould, K. L., Lipscomb, K. & Calvert, C. Compensatory changes of the distal coronary vascular bed during progressive coronary constriction. Circulation 51, 1085-1094 (1975).
21. Kaul, S. & Jayaweera, A. R. Determinants of microvascular flow. Eur. Heart J. 27, 2272-2274 (2006).
22. Uren, N. G. et al. Relation between myocardial blood flow and the severity of coronary-artery stenosis. N. Engl. J. Med. 330, 1782-1788 (1994).
23. Sen, S. et al. Diagnostic classification of the instantaneous wave-free ratio is equivalent to fractional flow reserve and is not improved with adenosine administration: Results of CLARIFY (Classification Accuracy of Pressure-Only Ratios Against Indices Using Flow Study). J. Am. Coll. Cardiol. 61, 1409-1420 (2013).
24. Wilson, R. F., Marcus, M. L. & White, C. W. Prediction of the physiologic significance of coronary arterial lesions by quantitative lesion geometry in patients with limited coronary artery disease. Circulation 75, 723-732 (1987).
25. Gould, K. L., Kirkeeide, R. L. & Buchi, M. Coronary flow reserve as a physiologic measure of stenosis severity. J. Am. Coll. Cardiol. 15, 459-474 (1990).
26. Hoffman, J. I. Maximal coronary flow and the concept of coronary vascular reserve. Circulation 70, 153-159 (1984).
27. McGinn, A. L., White, C. W. & Wilson, R. F. Interstudy variability of coronary flow reserve. Influence of heart rate, arterial pressure, and ventricular preload. Circulation 81, 1319-1330 (1990).
28. Rossen, J. D. & Winniford, M. D. Effect of increases in heart rate and arterial pressure on coronary flow reserve in humans. J. Am. Coll. Cardiol. 21, 343-348 (1993).
29. Hoffman, J. I. A critical view of coronary reserve. Circulation 75, I6-I11 (1987).
30. Hoffman, J. I. Problems of coronary flow reserve. Ann. Biomed. Eng. 28, 884-896 (2000).
31. Young, D. F., Cholvin, N. R., Kirkeeide, R. L. & Roth, A. C. Hemodynamics of arterial stenoses at elevated flow rates. Circ. Res. 41, 99-107 (1977).
32. Pijls, N. H., van Son, J. A., Kirkeeide, R. L., de Bruyne, B. & Gould, K. L. Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty. Circulation 87, 1354-1367 (1993).
33. Pijls, N. H. et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N. Engl. J. Med. 334, 1703-1708 (1996).
34. Pijls, N. H. et al. Fractional flow reserve: A useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow. Circulation 92, 3183-3193 (1995).
35. De Bruyne, B. et al. Simultaneous coronary pressure and flow velocity measurements in humans: Feasibility, reproducibility, and hemodynamic dependence of coronary flow velocity reserve, hyperemic flow versus pressure slope index, and fractional flow reserve. Circulation 94, 1842-1849 (1996).
36. Christou, M. A., Siontis, G. C., Katritsis, D. G. & Ioannidis, J. P. Meta-analysis of fractional flow reserve versus quantitative coronary angiography and noninvasive imaging for evaluation of myocardial ischemia. Am. J. Cardiol. 99, 450-456 (2007).
37. Meuwissen, M. et al. Role of fractional and coronary flow reserve in clinical decision making in intermediate coronary lesions. Interv. Cardiol. 1, 237-255 (2009).
38. De Bruyne, B., Bartunek, J., Sys, S. U. & Heyndrickx, G. R. Relation between myocardial fractional flow reserve calculated from coronary pressure measurements and exercise-induced myocardial ischemia. Circulation 92, 39-46 (1995).
39. Bech, G. J. et al. Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: A randomized trial. Circulation 103, 2928-2934 (2001).
40. De Bruyne, B. et al. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N. Engl. J. Med. 367, 991-1001 (2012).
41. Silber, S. et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur. Heart J. 26, 804-847 (2005).
42. Pijls, N. H. & Sels, J. W. Functional measurement of coronary stenosis. J. Am. Coll. Cardiol. 59, 1045-1057 (2012).
43. Kern, M. J. et al. Physiological assessment of coronary artery disease in the cardiac catheterization laboratory: A scientific statement from the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology. Circulation 114, 1321-1341 (2006).
44. Li, J. et al. Long-term outcomes of fractional flow reserve-guided vs. angiography-guided percutaneous coronary intervention in contemporary practice. Eur. Heart J. 34, 1375-1383 (2013).
45. Petraco, R. et al. Fractional flow reserve-guided revascularization: Practical implications of a diagnostic gray zone and measurement variability on clinical decisions. JACC Cardiovasc. Interv. 6, 222-225 (2013).
46. Marzilli, M. et al. Obstructive coronary atherosclerosis and ischemic heart disease: An elusive link! J. Am. Coll. Cardiol. 60, 951-956 (2012).
47. Pijls, N. H., Tanaka, N. & Fearon, W. F. Functional assessment of coronary stenoses: Can we live without it? Eur. Heart J. 34, 1335-1344 (2013).
48. Katikireddy, C. K., Mann, N., Brown, D., Van Tosh, A. & Stergiopoulos, K. Evaluation of myocardial ischemia and viability by noninvasive cardiac imaging. Expert Rev. Cardiovasc. Ther. 10, 55-73 (2012).
49. Spaan, J. A., Piek, J. J., Hoffman, J. I. & Siebes, M. Physiological basis of clinically used coronary hemodynamic indices. Circulation 113, 446-455 (2006).
50. Heusch, G. Adenosine and maximum coronary vasodilation in humans: Myth and misconceptions in the assessment of coronary reserve. Basic Res. Cardiol. 105, 1-5 (2010).
51. van de Hoef, T. P. et al. Coronary pressure-flow relations as basis for the understanding of coronary physiology. J. Mol. Cell. Cardiol. 52, 786-793 (2012).
52. Grattan, M. T., Hanley, F. L., Stevens, M. B. & Hoffman, J. I. Transmural coronary flow reserve patterns in dogs. Am. J. Physiol. 250, H276-H283 (1986).
53. Spaan, J. A., Breuls, N. P. & Laird, J. D. Diastolic-systolic coronary flow differences are caused by intramyocardial pump action in the anesthetized dog. Circ. Res. 49, 584-593 (1981).
54. Muller, O. et al. Pressure-diameter relationship in human coronary arteries. Circ. Cardiovasc. Interv. 5, 791-796 (2012).
55. Cornelissen, A. J., Dankelman, J., VanBavel, E., Stassen, H. G. & Spaan, J. A. Myogenic reactivity and resistance distribution in the coronary arterial tree: A model study. Am. J. Physiol. Heart Circ. Physiol. 278, H1490-H1499 (2000).
56. Kanatsuka, H., Ashikawa, K., Komaru, T., Suzuki, T. & Takishima, T. Diameter change and pressure-red blood cell velocity relations in coronary microvessels during long diastoles in the canine left ventricle. Circ. Res. 66, 503-510 (1990).
57. Chilian, W. M., Layne, S. M., Klausner, E. C., Eastham, C. L. & Marcus, M. L. Redistribution of coronary microvascular resistance produced by dipyridamole. Am. J. Physiol. 256, H383-H390 (1989).
58. Liu, Y. H., Bahn, R. C. & Ritman, E. L. Microvascular blood volume-to-flow relationships in porcine heart wall: Whole body CT evaluation in vivo. Am. J. Physiol. 269, H1820-H1826 (1995).
59. Le, D. E. et al. Changes in myocardial blood volume over a wide range of coronary driving pressures: Role of capillaries beyond the autoregulatory range. Heart 90, 1199-1205 (2004).
60. Hanley, F. L., Messina, L. M., Grattan, M. T. & Hoffman, I. E. The effect of coronary inflow pressure on coronary vascular resistance in the isolated dog heart. Circ. Res. 54, 760-772 (1984).
61. Verhoeff, B. J. et al. Influence of percutaneous coronary intervention on coronary microvascular resistance index. Circulation 111, 76-82 (2005).
62. Meuwissen, M. et al. Role of variability in microvascular resistance on fractional flow reserve and coronary blood flow velocity reserve in intermediate coronary lesions. Circulation 103, 184-187 (2001).
63. Chareonthaitawee, P., Kaufmann, P. A., Rimoldi, O. & Camici, P. G. Heterogeneity of resting and hyperemic myocardial blood flow in healthy humans. Cardiovasc. Res. 50, 151-161 (2001).
64. Chamuleau, S. A. et al. Association between coronary lesion severity and distal microvascular resistance in patients with coronary artery disease. Am. J. Physiol. Heart Circ. Physiol. 285, H2194-H2200 (2003).
65. Siebes, M. et al. Single-wire pressure and flow velocity measurement to quantify coronary stenosis hemodynamics and effects of percutaneous interventions. Circulation 109, 756-762 (2004).
66. van de Hoef, T. P. et al. Diagnostic accuracy of combined intracoronary pressure and flow velocity information during baseline conditions: Adenosine-free assessment of functional coronary lesion severity. Circ. Cardiovasc. Interv. 5, 508-514 (2012).
67. Meuwissen, M. et al. Hyperemic stenosis resistance index for evaluation of functional coronary lesion severity. Circulation 106, 441-446 (2002).
68. Marques, K. M. et al. The diastolic flow velocity-pressure gradient relation and dpv50 to assess the hemodynamic significance of coronary stenoses. Am. J. Physiol. Heart Circ. Physiol. 291, H2630-H2635 (2006).
69. Pijls, N. H., Kern, M. J., Yock, P. G. & De Bruyne, B. Practice and potential pitfalls of coronary pressure measurement. Catheter. Cardiovasc. Interv. 49, 1-16 (2000).
70. Vranckx, P. et al. Coronary pressure-derived fractional flow reserve measurements: Recommendations for standardization, recording, and reporting as a core laboratory technique: Proposals for integration in clinical trials. Circ. Cardiovasc. Interv. 5, 312-317 (2012).
71. Berne, R. M., Rubio, R., Dobson, J. G. Jr & Curnish, R. R. Adenosine and adenine nucleotides as possible mediators of cardiac and skeletal muscle blood flow regulation. Circ. Res. 28 (Suppl. 1), 115+ (1971).
72. Berne, R. M. Cardiac nucleotides in hypoxia: Possible role in regulation of coronary blood flow. Am. J. Physiol. 204, 317-322 (1963).
73. Jones, C. J., Kuo, L., Davis, M. J., DeFily, D. V. & Chilian, W. M. Role of nitric oxide in the coronary microvascular responses to adenosine and increased metabolic demand. Circulation 91, 1807-1813 (1995).
74. Bassenge, E. & Heusch, G. Endothelial and neuro-humoral control of coronary blood flow in health and disease. Rev. Physiol. Biochem. Pharmacol. 116, 77-165 (1990).
75. Deussen, A., Ohanyan, V., Jannasch, A., Yin, L. & Chilian, W. Mechanisms of metabolic coronary flow regulation. J. Mol. Cell. Cardiol. 52, 794-801 (2012).
76. Deussen, A., Brand, M., Pexa, A. & Weichsel, J. Metabolic coronary flow regulation - current concepts. Basic Res. Cardiol. 101, 453-464 (2006).
77. Duncker, D. J. & Bache, R. J. Regulation of coronary blood flow during exercise. Physiol. Rev. 88, 1009-1086 (2008).
78. Auchampach, J. A. & Bolli, R. Adenosine receptor subtypes in the heart: Therapeutic opportunities and challenges. Am. J. Physiol. 276, H1113-H1116 (1999).
79. Cohen, M. V. & Downey, J. M. Adenosine: Trigger and mediator of cardioprotection. Basic Res. Cardiol. 103, 203-215 (2008).
80. Heusch, G., Boengler, K. & Schulz, R. Cardioprotection: Nitric oxide, protein kinases, and mitochondria. Circulation 118, 1915-1919 (2008).
81. Sylven, C. Mechanisms of pain in angina pectoris - a critical review of the adenosine hypothesis. Cardiovasc. Drugs Ther. 7, 745-759 (1993).
82. Schulz, R. & Heusch, G. Extracellular adenosine attenuates left ventricular hypertrophy through its impact on the protein kinase and phosphatase interaction. Hypertension 51, 1474-1475 (2008).
83. Baumgart, D. et al. Augmented α-adrenergic constriction of atherosclerotic human coronary arteries. Circulation 99, 2090-2097 (1999).
84. Gregorini, L. et al. Effects of selective α1- and α2-adrenergic blockade on coronary flow reserve after coronary stenting. Circulation 106, 2901-2907 (2002).
85. Gregorini, L. et al. α-adrenergic blockade improves recovery of myocardial perfusion and function after coronary stenting in patients with acute myocardial infarction. Circulation 99, 482-490 (1999).
86. Rimoldi, O. et al. Limitation of coronary reserve after successful angioplasty is prevented by oral pretreatment with an α1-adrenergic antagonist. J. Cardiovasc. Pharmacol. 36, 310-315 (2000).
87. Kolyva, C., Verhoeff, B. J., Spaan, J. A., Piek, J. J. & Siebes, M. Increased diastolic time fraction as beneficial adjunct of α1-adrenergic receptor blockade after percutaneous coronary intervention. Am. J. Physiol. Heart Circ. Physiol. 295, H2054-H2060 (2008).
88. Barbato, E. et al. α-adrenergic receptor blockade and hyperaemic response in patients with intermediate coronary stenoses. Eur. Heart J. 25, 2034-2039 (2004).
89. Aarnoudse, W. et al. Effect of phentolamine on the hyperemic response to adenosine in patients with microvascular disease. Am. J. Cardiol. 96, 1627-1630 (2005).
90. Loghin, C., Sdringola, S. & Gould, K. L. Does coronary vasodilation after adenosine override endothelin-1-induced coronary vasoconstriction? Am. J. Physiol. Heart Circ. Physiol. 292, H496-H502 (2007).
91. Leineweber, K. et al. Intense vasoconstriction in response to aspirate from stented saphenous vein aortocoronary bypass grafts. J. Am. Coll. Cardiol. 47, 981-6 (2006).
92. Mangiacapra, F. et al. Intracoronary enalaprilat to reduce microvascular damage during percutaneous coronary intervention (ProMicro) study. J. Am. Coll. Cardiol. 61, 615-621 (2013).
93. Wilson, R. F., Wyche, K., Christensen, B. V., Zimmer, S. & Laxson, D. D. Effects of adenosine on human coronary arterial circulation. Circulation 82, 1595-1606 (1990).
94. De Luca, G., Venegoni, L., Iorio, S., Giuliani, L. & Marino, P. Effects of increasing doses of intracoronary adenosine on the assessment of fractional flow reserve. JACC Cardiovasc. Intv. 4, 1079-1084 (2011).
95. Rioufol, G. et al. 150 microgram intracoronary adenosine bolus for accurate fractional flow reserve assessment of angiographically intermediate coronary stenosis. EuroIntervention 1, 204-207 (2005).
96. Cubero, J. M. et al. A comparative study between intravenous and intracoronary administration of high doses adenosine for fractional flow reserve measurements, in the "FAME" era [abstract]. J. Am. Coll. Cardiol. 59, E1465 (2012).
97. López-Palop, R. et al. Comparison of effectiveness of high-dose intracoronary adenosine versus intravenous administration on the assessment of fractional flow reserve in patients with coronary heart disease. Am. J. Cardiol. 111, 1277-1283 (2013).
98. Leone, A. M. et al. Maximal hyperemia in the assessment of fractional flow reserve: Intracoronary adenosine versus intracoronary sodium nitroprusside versus intravenous adenosine: The NASCI (Nitroprussiato versus Adenosina nelle Stenosi Coronariche Intermedie) study. JACC Cardiovasc. Interv. 5, 402-408 (2012).
99. Jeremias, A. et al. Adequacy of intracoronary versus intravenous adenosine-induced maximal coronary hyperemia for fractional flow reserve measurements. Am. Heart J. 140, 651-657 (2000).
100. De Bruyne, B. et al. Intracoronary and intravenous adenosine 5'-triphosphate, adenosine, papaverine, and contrast medium to assess fractional flow reserve in humans. Circulation 107, 1877-1883 (2003).
101. Koo, B. K. et al. Intracoronary continuous adenosine infusion. Circ. J. 69, 908-912 (2005).
102. Yoon, M. H. et al. Comparison of the intracoronary continuous infusion method using a microcatheter and the intravenous continuous adenosine infusion method for inducing maximal hyperemia for fractional flow reserve measurement. Am. Heart J. 157, 1050-1056 (2009).
103. Seo, M. K. et al. Comparison of hyperemic efficacy between central and peripheral venous adenosine infusion for fractional flow reserve measurement. Circ. Cardiovasc. Interv. 5, 401-405 (2012).
104. Petraco, R. et al. Classification performance of instantaneous wave-free ratio (iFR) and fractional flow reserve in a clinical population of intermediate coronary stenoses: Results of the ADVISE registry. EuroIntervention 9, 91-101 (2013).
105. Casella, G. et al. Are high doses of intracoronary adenosine an alternative to standard intravenous adenosine for the assessment of fractional flow reserve? Am. Heart J. 148, 590-595 (2004).
106. Pijls, N. H., Kern, M. J., Yock, P. G. & De Bruyne, B. Practice and potential pitfalls of coronary pressure measurement. Catheter. Cardiovasc. Interv. 49, 1-16 (2000).
107. Siebes, M., Chamuleau, S. A., Meuwissen, M., Piek, J. J. & Spaan, J. A. Influence of hemodynamic conditions on fractional flow reserve: Parametric analysis of underlying model. Am. J. Physiol. Heart Circ. Physiol. 283, H1462-H1470 (2002).
108. Donohue, T. J. et al. Assessing the hemodynamic significance of coronary artery stenoses: Analysis of translesional pressure-flow velocity relations in patients. J. Am. Coll. Cardiol. 22, 449-458 (1993).
109. Piek, J. J. et al. Angiographical and Doppler flow-derived parameters for assessment of coronary lesion severity and its relation to the result of exercise electrocardiography. DEBATE study group. Doppler Endpoints Balloon Angioplasty Trial Europe. Eur. Heart J. 21, 466-474 (2000).
110. Lamm, C., Albertsson, P., Dohnal, M., Tylen, U. & Emanuelsson, H. Assessment of coronary artery stenosis during PTCA by measurement of the trans-stenotic pressure gradient. Comparison with quantitative coronary angiography. Eur. Heart J. 16, 1367-1374 (1995).
111. Mamas, M. A. et al. Resting Pd/Pa measured with intracoronary pressure wire strongly predicts fractional flow reserve. J. Invasive Cardiol. 22, 260-265 (2010).
112. Brosh, D. et al. Pulse transmission coefficient: A nonhyperemic index for physiologic assessment of procedural success following percutaneous coronary interventions. Catheter. Cardiovasc. Interv. 61, 95-102 (2004).
113. Brosh, D. et al. Pulse transmission coefficient: A novel nonhyperemic parameter for assessing the physiological significance of coronary artery stenoses. J. Am. Coll. Cardiol. 39, 1012-1019 (2002).
114. Sen, S. et al. Development and validation of a new adenosine-independent index of stenosis severity from coronary wave-intensity analysis: Results of the ADVISE (ADenosine Vasodilator Independent Stenosis Evaluation) study. J. Am. Coll. Cardiol. 59, 1392-1402 (2012).
115. Berry, C. et al. VERIFY (VERification of Instantaneous wave-free ratio and Fractional flow reserve for the assessment of coronary artery stenosis severity in everydaY practice): A multicenter study in consecutive patients. J. Am. Coll. Cardiol. 61, 1421-1427 (2013).
116. Samady, H. & Gogas, B. D. Does flow during rest and relaxation suffice? J. Am. Coll. Cardiol. 61, 1436-1439 (2013).
117. Duncker, D. J. & Bache, R. J. Effect of chronotropic and inotropic stimulation on the coronary pressure-flow relation in left ventricular hypertrophy. Basic Res. Cardiol. 92, 271-286 (1997).
118. Jeremy, R. W., Hughes, C. F. & Fletcher, P. J. Effects of left ventricular diastolic pressure on the pressure-flow relation of the coronary circulation during physiological vasodilatation. Cardiovasc. Res. 20, 922-930 (1986).
119. Duncker, D. J., Zhang, J., Pavek, T. J., Crampton, M. J. & Bache, R. J. Effect of exercise on coronary pressure-flow relationship in hypertrophied left ventricle. Am. J. Physiol. 269, H271-H281 (1995).
120. Jimenez-Navarro, M. et al. Measurement of fractional flow reserve to assess moderately severe coronary lesions: Correlation with dobutamine stress echocardiography. J. Interv. Cardiol. 14, 499-504 (2001).
121. Rieber, J. et al. Comparison of pressure measurement, dobutamine contrast stress echocardiography and SPECT for the evaluation of intermediate coronary stenoses. The COMPRESS trial. Int. J. Cardiovasc. Intervent. 6, 142-147 (2004).
122. Erhard, I. et al. The validation of fractional flow reserve in patients with coronary multivessel disease: A comparison with SPECT and contrast-enhanced dobutamine stress echocardiography. Z. Kardiol. 94, 321-327 (2005).
123. Hacker, M. et al. Comparison of Tc-99m sestamibi SPECT with fractional flow reserve in patients with intermediate coronary artery stenoses. J. Nucl. Cardiol. 12, 645-654 (2005).
124. Tron, C. et al. Comparison of pressure-derived fractional flow reserve with poststenotic coronary flow velocity reserve for prediction of stress myocardial perfusion imaging results. Am. Heart J. 130, 723-733 (1995).
125. Bartunek, J., Van Schuerbeeck, E. & de Bruyne, B. Comparison of exercise electrocardiography and dobutamine echocardiography with invasively assessed myocardial fractional flow reserve in evaluation of severity of coronary arterial narrowing. Am. J. Cardiol. 79, 478-481 (1997).
126. Caymaz, O. et al. Correlation of myocardial fractional flow reserve with thallium-201 SPECT imaging in intermediate-severity coronary artery lesions. J. Invasive Cardiol. 12, 345-350 (2000).
127. Fearon, W. F. et al. Use of fractional myocardial flow reserve to assess the functional significance of intermediate coronary stenoses. Am. J. Cardiol. 86, 1013-1014, A10 (2000).
128. Chamuleau, S. A. et al. Fractional flow reserve, absolute and relative coronary blood flow velocity reserve in relation to the results of technetium-99m sestamibi single-photon emission computed tomography in patients with two-vessel coronary artery disease. J. Am. Coll. Cardiol. 37, 1316-1322 (2001).
129. Seo, J. K. et al. Early dipyridamole stress myocardial SPECT to detect residual stenosis of infarct related artery: Comparison with coronary angiography and fractional flow reserve. Korean J. Intern. Med. 17, 7-13 (2002).
130. Kruger, S. et al. Use of fractional flow reserve versus stress perfusion scintigraphy in stent restenosis. Eur. J. Intern. Med. 16, 429-431 (2005).
131. Samady, H. et al. Fractional flow reserve of infarct-related arteries identifies reversible defects on noninvasive myocardial perfusion imaging early after myocardial infarction. J. Am. Coll. Cardiol. 47, 2187-2193 (2006).
132. Bartunek, J. et al. Dobutamine-induced wall motion abnormalities: Correlations with myocardial fractional flow reserve and quantitative coronary angiography. J. Am. Coll. Cardiol. 27, 1429-1436 (1996).
133. Abe, M., Tomiyama, H., Yoshida, H. & Doba, N. Diastolic fractional flow reserve to assess the functional severity of moderate coronary artery stenoses: Comparison with fractional flow reserve and coronary flow velocity reserve. Circulation 102, 2365-2370 (2000).
134. De Bruyne, B. et al. Fractional flow reserve in patients with prior myocardial infarction. Circulation 104, 157-162 (2001).
135. Yanagisawa, H. et al. Correlation between thallium-201 myocardial perfusion defects and the functional severity of coronary artery stenosis as assessed by pressure-derived myocardial fractional flow reserve. Circ. J. 66, 1105-1109 (2002).
136. Ziaee, A. et al. Lack of relation between imaging and physiology in ostial coronary artery narrowings. Am. J. Cardiol. 93, 1404-1407 (2004).
137. Morishima, T. et al. Correlation between myocardial uptake of technetium-99m-sestamibi and pressure-derived myocardial fractional flow reserve. J. Cardiol. 43, 155-163 (2004).
138. Kobori, Y., Tanaka, N., Takazawa, K. & Yamashina, A. Usefulness of fractional flow reserve in determining the indication of target lesion revascularization. Catheter. Cardiovasc. Interv. 65, 355-360 (2005).
139. Ragosta, M. et al. Comparison between angiography and fractional flow reserve versus single-photon emission computed tomographic myocardial perfusion imaging for determining lesion significance in patients with multivessel coronary disease. Am. J. Cardiol. 99, 896-902 (2007).